108 related articles for article (PubMed ID: 830975)
1. Bone marrow acid phosphatase: prognostic value in patients undergoing radical prostatectomy.
Veenema RJ; Gursel EO; Romas N; Wechsler M; Lattimer JK
J Urol; 1977 Jan; 117(1):81-2. PubMed ID: 830975
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow acid phosphatase: another look.
Khan R; Turner B; Edson M; Dolan M
J Urol; 1977 Jan; 117(1):79-80. PubMed ID: 830974
[TBL] [Abstract][Full Text] [Related]
3. Cancer of the prostate and other prostatic problems.
Derrick FC
Postgrad Med; 1973 Oct; 54(4):123-6. PubMed ID: 4125730
[No Abstract] [Full Text] [Related]
4. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
Urol Res; 1999 Aug; 27(4):285-90. PubMed ID: 10460901
[TBL] [Abstract][Full Text] [Related]
5. A reappraisal of total prostatectomy for prostatic cancer.
Bruce PT
Med J Aust; 1970 May; 1(22):1103-5. PubMed ID: 5430489
[No Abstract] [Full Text] [Related]
6. Preoperative serum levels of early prostate cancer antigen (EPCA) predict prostate cancer progression in patients undergoing radical prostatectomy.
Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
Prostate; 2012 Feb; 72(3):270-9. PubMed ID: 21630293
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of bone marrow acid phosphatase and bone scanning in staging of prostatic cancer.
Gursel EO; Rezvan M; Sy FA; Veenema RJ
J Urol; 1974 Jan; 111(1):53-7. PubMed ID: 4813553
[No Abstract] [Full Text] [Related]
8. The value of serum prostate specific antigen determinations before and after radical prostatectomy.
Lange PH; Ercole CJ; Lightner DJ; Fraley EE; Vessella R
J Urol; 1989 Apr; 141(4):873-9. PubMed ID: 2467013
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis of prostatic cancer.
Murphy GP
Cancer; 1976 Jan; 37(1 suppl):589-96. PubMed ID: 1247985
[TBL] [Abstract][Full Text] [Related]
10. Primary transitional cell carcinoma of the prostate.
Greene LF; O'Dea MJ; Dockerty MB
J Urol; 1976 Dec; 116(6):761-3. PubMed ID: 1003646
[TBL] [Abstract][Full Text] [Related]
11. EXPERIENCES WITH ASPIRATION BIOPSIES OF THE BONE MARROW IN THE DIAGNOSIS AND PROGNOSIS OF CARCINOMA OF THE PROSTATE GLAND.
WELSH JF; MACKINNEY CC
Am J Clin Pathol; 1964 May; 41():509-12. PubMed ID: 14165456
[No Abstract] [Full Text] [Related]
12. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
Moul JW; Connelly RR; Perahia B; McLeod DG
J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
[TBL] [Abstract][Full Text] [Related]
13. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
Gleason DF; Mellinger GT
J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
[No Abstract] [Full Text] [Related]
14. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
[TBL] [Abstract][Full Text] [Related]
15. New diagnostic use of bone marrow acid and alkaline phosphatase.
Yarrison G; Mertens BF; Mathies JC
Am J Clin Pathol; 1976 Oct; 66(4):667-71. PubMed ID: 970368
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.
Cole AI; Morgan TM; Spratt DE; Palapattu GS; He C; Tomlins SA; Weizer AZ; Feng FY; Wu A; Siddiqui J; Chinnaiyan AM; Montgomery JS; Kunju LP; Miller DC; Hollenbeck BK; Wei JT; Mehra R
J Urol; 2016 Aug; 196(2):405-11. PubMed ID: 26920466
[TBL] [Abstract][Full Text] [Related]
17. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
Shariat SF; Shalev M; Menesses-Diaz A; Kim IY; Kattan MW; Wheeler TM; Slawin KM
J Clin Oncol; 2001 Jun; 19(11):2856-64. PubMed ID: 11387358
[TBL] [Abstract][Full Text] [Related]
18. Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy.
Goldrath DE; Messing EM
J Urol; 1989 Oct; 142(4):1082-4. PubMed ID: 2477560
[TBL] [Abstract][Full Text] [Related]
19. A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness.
Diamond DA; Berry SJ; Jewett HJ; Eggleston JC; Coffey DS
J Urol; 1982 Oct; 128(4):729-34. PubMed ID: 7143594
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center.
Albadine R; Hyndman ME; Chaux A; Jeong JY; Saab S; Tavora F; Epstein JI; Gonzalgo ML; Pavlovich CP; Netto GJ
Hum Pathol; 2012 Feb; 43(2):254-60. PubMed ID: 21820147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
